Literature DB >> 1643303

Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth.

M Tala-Heikkilä1, T Nurmela, O Misljenovic, M A Bleiker, E Tala.   

Abstract

OBJECTIVE: To determine the degree of and variation in sensitivity to PPD RT 23 tuberculin and M. scrofulaceum sensitin RS 95 at school age in children BCG vaccinated at birth.
DESIGN: Double-testing by applying standard WHO Mantoux tests and inspecting BCG scars. SETTING AND PARTICIPANTS: Urban and rural schools in Southwest Finland, 1091 children aged 11-13 years. MAIN OUTCOME MEASURES: Size of tuberculin and sensitin indurations and BCG scar (mm).
RESULTS: The mean size of tuberculin indurations was 7.2 mm, sensitin indurations 8.1 mm and BCG scars 7.9 mm. The reaction to sensitin was significantly larger than to tuberculin (95% confidence interval 0.58-1.10 mm) and the zero reactions to sensitin were fewer. Correlation between tuberculin and sensitin indurations was significant (r = 0.75, 95% confidence interval 0.72-0.77). There were induration greater than or equal to 15 mm to tuberculin in 16% and to sensitin in 14%. Sensitin indurations exceeded those of tuberculin by 4 mm or more in 14% of the children with at least 5 mm tuberculin indurations.
CONCLUSIONS: High tuberculin sensitivity in healthy schoolchildren may be partially maintained by contact with environmental mycobacteria. Our data do not prove but very probably indicate that children have protective immunity. In view of the current incidence of tuberculosis in Finland and the likelihood that lymph node infections and sensitivity to environmental mycobacteria will increase, continued BCG vaccination at birth is recommended.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643303     DOI: 10.1016/0962-8479(92)90061-N

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  5 in total

1.  Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong.

Authors:  C C Leung; W W Yew; C M Tam; C K Chan; K C Chang; W S Law; S N Lee; M Y Wong; K F Au
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

2.  Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Authors:  Janine Jason; Lennox K Archibald; Okey C Nwanyanwu; Peter N Kazembe; Julie A Chatt; Elizabeth Norton; Hamish Dobbie; William R Jarvis
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 3.  BCG vaccination in India and tuberculosis in children: newer facets.

Authors:  P M Udani
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

4.  Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.

Authors:  R Diel; A Nienhaus; C Lange; K Meywald-Walter; M Forssbohm; T Schaberg
Journal:  Respir Res       Date:  2006-05-17

5.  BCG vaccination at three different age groups: response and effectiveness.

Authors:  George Briassoulis; Irene Karabatsou; Vasilis Gogoglou; Athina Tsorva
Journal:  J Immune Based Ther Vaccines       Date:  2005-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.